Cambridge Capital Group
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- USA
- France
Investment stages
- Pre-Seed
- Seed
Industries
- Fintech
- AI
- Health Tech
- Internet
About
Cambridge Capital Group, headquartered in Cambridge, United Kingdom, has been a leading business angel group since 2001. They consist of over 80 investors, including private investors, family offices, and venture funds, who have invested more than £30M in over 100 hitech startups within the UK's Golden Triangle. The group focuses on seed, startup, and early growth opportunities, and invests in several sectors, including LegalTech, Robotics, Cybersecurity, and Biotech. Notable exits include the sale of Swiftkey to Microsoft for $250 million. CCG is recognized for its thorough investment philosophy and a strong track record of successful exits and high financial returns for its members.
Cambridge Capital Group, headquartered in Cambridge, United Kingdom, has been a leading business angel group since 2001. They consist of over 80 investors, including private investors, family offices, and venture funds, who have invested more than £30M in over 100 hitech startups within the UK's Golden Triangle. The group focuses on seed, startup, and early growth opportunities, and invests in several sectors, including LegalTech, Robotics, Cybersecurity, and Biotech. Notable exits include the sale of Swiftkey to Microsoft for $250 million. CCG is recognized for its thorough investment philosophy and a strong track record of successful exits and high financial returns for its members.
Investment Thesis
Cambridge Capital Group focuses on investing in early stage Technology startups primarily based within the UK's Golden Triangle. Their aim is to back innovative and high potential hitech businesses.
Portfolio
Cytochroma
Porotech
Qualus
Cambridge GaN Devices
Boutros Bear
Porotech
Lightpoint Medical
Obrizum
Sorex Sensors
Ablatus Therapeutics